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OBJECTIVE: The aim of this study was to determine the incidence of asymptomatic, histologically proven prostatitis in men with 
symptoms of benign prostate hyperplasia and to observe the correlation between asymptomatic prostatitis and prostate specific 
antigen (PSA) density.
INTRODUCTION: The incidence of type IV prostatitis is unknown. There is a tendency to correlate the presence of inflamma-
tory prostatitis with an elevation of PSA. 
MATERIALS AND METHODS: From August 2000 to January 2006, 183 patients who underwent surgical treatment for benign 
prostate hyperplasia as a result of obstructive or irritative symptoms were prospectively studied. In accordance with the histology 
findings, these patients were divided into two groups: group I included patients with the presence of histological prostatitis and 
group II included patients with the absence of histological prostatitis. The mean PSA densities were compared.
RESULTS: Histological evidence of prostatitis was observed in 145 patients. In this group, the mean PSA density was 0.136 
± 0.095. In 38 cases, there was no evidence of inflammation upon histological examination of the surgical samples. In these 38 
cases, the mean PSA density was 0.126 ± 0.129. No statistically significant differences were detected between the two groups; the 
p-value is 0.124.
CONCLUSION: Abnormal PSA density should not be attributed to the inflammatory prostatitis process.
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INTRODUCTION
Chronic prostatitis is a disease with uncertain etiology. 
The typical histological appearance of chronic prostatitis 
is defined by the invasion of leukocytes, especially 
polymorphonuclear leukocytes, into prostatic ducts and the 
periprostatic tissue.1,2 The clinical presentation of prostatitis 
is widely variable, ranging from asymptomatic patients to 
patients with chronic, potentially incapacitating, pelvic pain.
The 1995 National Institute of Health (NIH) 
classification divides prostatitis into four categories: type I 
and type II are associated with bacterial infection, type III 
is associated with chronic pelvic pain with (IIIa) or without 
(IIIb) inflammation of the gland, and type IV includes 
asymptomatic patients in which the diagnosis is made after 
a biopsy for elevated prostate specific antigen (PSA), an 
abnormal digital rectal examination, or an examination of 
surgical specimens from transurethral or open surgery for 
benign prostatic hyperplasia. 
The incidence of type IV prostatitis is unknown. There 
is a tendency to correlate inflammatory prostatitis with an 
elevation of PSA. Despite this controversy, when prostatitis 
is found in biopsy samples of patients with an elevated 
PSA, the rise in PSA is usually attributed to the presence of 
prostatitis.
The aim of this study was to determine the incidence 
of asymptomatic, histologically proven prostatitis in men 
with symptoms of benign prostate hyperplasia (BPH) and 
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to observe the correlation between asymptomatic prostatitis 
and PSA density.
MATERIALS AND METHODS
From August 2000 to January 2006, 183 patients who 
underwent surgical treatment for BPH due to obstructive 
or irritative symptoms were prospectively studied. Of 
these patients, 45 were treated by open surgery and 138 by 
transuretheral resection of the prostate (TURP). Patients who 
complained of chronic pelvic pain or who had a history or 
laboratory exam suggesting acute prostatitis were excluded.
All patients underwent a digital rectal examination, 
serum PSA measurement, and supra pubic ultrasonograph 
of the prostate with volume measurement before surgery.
After surgery, the patients were divided into two groups 
according to the histological findings: group I included 
patients with the presence of histological prostatitis and 
group II included patients with the absence of histological 
prostatitis. A single pathologist with extensive experience 
in urological pathology reviewed all cases. The mean PSA 
densities obtained for groups I and II were compared using 
the Student’s t-test.
 
RESULTS
Histological evidence of chronic prostatitis was 
present in 145 (78%) of the surgical specimens. The mean 
PSA density in this group of patients was 0.136 ± 0.095. 
Among 38 cases, no signs of inflammation were observed 
on histological examination of the surgical samples. In 
this group, the mean PSA density was 0.126 ± 0.129. No 
statistical difference was detected between these two groups 
(p=0.124). The mean age, international prostate symptom 
score (IPSS), prostate volume, PSA, and PSA density of 
both groups are listed in Table 1.
DISCUSSION
Histological evidence of prostatitis in asymptomatic 
men appears to be very common. Nickel et al. reported 
inflammation in all 80 specimens reviewed from material 
obtained after the patients underwent TURP.1 In a similar 
study, Khoen et al. found a 98% incidence of prostatitis 
in 168 asymptomatic patients.3 In studies utilizing biopsy 
sample analysis, a more variable incidence of prostatitis, 
ranging from 17.2% to 47%, was obtained.4
However, whether these inflammatory findings correlate 
with elevated PSA levels remains controversial. Clinical 
data are available in support of this theory;5,6 however, other 
studies were unable to establish a correlation.4,7 It should 
also be noted that well differentiated prostate cancer may 
correlate with extraprostatic disease.8
In some patients, the area of inflammation may be very 
small. One study evaluated the correlation between PSA 
level, inflammatory cell density, and foci of inflammation 
(glandular, peri-glandular, stromal, or peri-urethral). No 
difference was observed in PSA levels when stratifying by 
any of the other variables.1
In the present study, a high incidence of asymptomatic, 
histologically proven prostatitis was found (78%). As the 
two groups in this study were not homogeneous regarding 
the volume of the prostate, we decided to compare the PSA 
density instead of the total PSA value. Using this method, 
it was possible to exclude the influence of prostatic mass on 
the results.
In the group with no histologically proven prostatitis, 
the mean PSA density was 0136 ± 0.095. In comparison, the 
PSA density was 0.126 ± 0.095 in men with no prostatitis. 
No statistically significant difference was detected between 
the patients with prostatitis and those without prostatitis. 
These data suggest that the incidental finding of histological 
prostatitis is very common and is not correlated with an 
increased PSA value. 
CONCLUSION
Patients with an elevated PSA and histologically proven, 
asymptomatic inflammation of the prostate should continue 
with regular follow-ups and treatment. The abnormal PSA 
level does not seem to be attributed to the inflammatory 
process.
Table 1 - Patients characteristics of group I and group II
N Age IPSS Prostate Volume PSA PSA density p
Group I 145 67 ± 4.3 19 ± 6.1 39.2 ± 10.5 5.1 ± 2.5 0.13 ± 0.095 0.124
Group II 38 64 ± 5.2 21 ± 4.2 42.4 ± 12.3 5.3 ±3.2 0.126 ± 0.129
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